Study of Different Therapeutic Agents for the Prevention of Ischemia Reperfusion Injury in Free Skin Flap

1- Ames A. 3rd, Wright R.L., Kowada M., Thurston J.M.
and Majno G.: Cerebral ischemia. II. The no-reflow
phenomenon. Am. J. Pathol., 52 (2): 437-453, 1968.
Egypt, J. Plast. Reconstr. Surg., January 2019 99
2- May J.W. Jr., Chait L.A., O'Brien B.M. and Hurley J.V.:
The no-reflow phenomenon in experimental free flaps.
Plast. Reconstr. Surg., 61 (2): 256-67, 1978.
3- Kroll S.S., Schusterman M.A., Reece G.P., Miller M.J.,
Evans G.R., Robb G.L. and Baldwin B.J.: Choice of flap
and incidence of free flap success. Plast. Reconstr. Surg.,
98 (3): 459-63, 1996.
4- Bui D.T., Cordeiro P.G., Hu Q.-Y., Disa J.J., Pusic A. and
Mehrara B.J.: Free flap reexploration: Indications, treatment,
and outcomes in 1193 free flaps. Plast. Reconstr.
Surg., 119: 2092, 2007.
5- Davis Sears E. and Chung K.C.: Replantation of finger
avulsion injuries: A systematic review of survival and
functional outcomes. J. Hand Surg. Am., 36: 686-694,
2011.
6- Suominen S. and Asko-Seljavaara S.: Free flap failures.
Microsurgery, 16: 396, 1995.
7- Schmidt Y., Bannasch H. and Eisenhardt S.U.: Ischemiareperfusion
injury leads to significant tissue damage in
free flap surgery. Plast. Reconstr. Surg., 129 (1): 174e-
175e, 2012.
8- Kerrigan C.L. and Daniel R.K.: Pharmacologic treatment
of the failing skin flap. Plast. Reconstr. Surg. Nov., 70
(5): 541-9, 1982.
9- Wray R.C. Jr. and Young V.L.: Drug treatment and flap
survival. Plast. Reconstr. Surg.,73 (6): 939-42, 1984.
10- Pang C.Y., Forrest C.R. and Mounsey R.: Pharmacologic
intervention in ischemia-induced reperfusion injury in
the skeletal muscle. Microsurgery, 14 (3): 176-82, 1993.
11- Knight K.R.: Review of postoperative pharmacological
infusions in ischemic skin flaps. Microsurgery, 15: 675-
684, 1994.
12- Zaccaria A., Weinzweig N., Yoshitake M., et al.: Vitamin
C reduces ischemia-reperfusion injury in a rat epigastric
island skin flap model. Ann. Plast. Surg., 33: 620-623,
1994.
13- Li X., Cooley B.C., Fowler J.D. and Gould J.S.: Intravascular
heparin protects muscle flaps from ischemia / reperfusion
injury. Microsurgery, 16 (2): 90-93, 1995.
14- Tosa Y., Lee W.P., Kollias N., Randolph M.A. and May
J.W.: Monoclonal antibody to intercellular adhesion
molecule 1 protects skin flaps against ischemia-reperfusion
injury: An experimental study in rats. Plast. Reconstr.
Surg., 10: 1586-94, 1998.
15- Cahoon N.J., Naparus A., Ashrafpour H., Hofer S.O.,
Huang N., Lipa J.E., Forrest C.R. and Pang C.Y.: Pharmacologic
prophylactic treatment for perioperative protection
of skeletal muscle from ischemia-reperfusion
injury in reconstructive surgery. Plast. Reconstr. Surg.,
131 (3): 473-85, 2013.
16- Feller A.M., Roth A.C., Russell R.C., Eagleton B., Suchy
H. and Debs N.: Experimental evaluation of oxygen free
radical scavengers in the prevention of reperfusion injury
to skeletal muscle. Ann. Plast. Surg., 22: 321-331, 1989.
17- Van den Heuvel M.G., Bast A., Haenen G.R., Ambergen
A.W., Mermans J.F. and van der Hulst R.R.: The role of
antioxidants in ischemia-reperfusion in a human DIEP
flap model. J. Plast. Reconstr. Aesthet. Surg., 65 (12):
1706-11, 2012.
18- Yin Z., Ren H., Liu L., Chen W., Gan C., Jiao H. and Fan
J.: Thioredoxin Protects Skin Flaps from Ischemia-
Reperfusion Injury: A Novel Prognostic and Therapeutic
Target. Plast. Reconstr. Surg., 137 (2): 511-21, 2016.
19- Wright J.G., Kerr J.C., Valeri C.R. and Hobson R.W. 2nd:
Heparin decreases ischemia-reperfusion injury in isolated
canine gracilis model. Arch. Surg., 123 (4): 470-2, 1988.
20- Hobson R.W. 2nd, Neville R., Watanabe B., Canady J.,
Wright J.G. and Belkin M.: Role of heparin in reducing
skeletal muscle infarction in ischemia-reperfusion. Microcirc
Endothelium Lymphatics, 5 (3-5): 259-76, 1989.
21- Gedik H.S., Korkmaz K., Erdem H., Karakilic E., Lafci
G. and Ankarali H.: Protective effect of heparin in the
end organ ischemia/reperfusion injury of the lungs and
heart. J. Cardiothoracic. Surg., 15 (7): 123, 2012.
22- Yener A.Ü., Çiçek M.C., Genç S.B., Özkan T., Dog˘an E.,
Bilgin B.C., Akın T., Erdem H. and Ankarali H.: Protective
role of heparin in the injury of the liver and kidney on
the experimental model of ischemia/reperfusion. J. Cardiothorac.
Surg.,17 (9): 35, 2014.
23- Mousavi S., Moradi M., Khorshidahmad T. and Motamedi
M.: Anti-Inflammatory Effects of Heparin and Its Derivatives:
A Systematic Review. Adv. Pharmacol. Sci., 2015:
507151, 2015.
24- Lever R., Hoult J.R. and Page C.P.: The effects of heparin
and related molecules upon the adhesion of human polymorphonuclear
leucocytes to vascular endothelium in
vitro. Br. J. Pharmacol., 129: 533-40, 2000.
25- Dandona P., Qutob T., Hamouda W., Bakri F., Aljada A.
and Kumbkarni Y.: Heparin inhibits reactive oxygen
species generation by polymorphonuclear and mononuclear
leucocytes. Thromb. Res., 15; 96 (6): 437-43, 1999.
26- Thourani V.H., Brar S.S., Kennedy T.P., Thornton L.R.,
Watts J.A., Ronson R.S., Zhao Z.Q., Sturrock A.L., Hoidal
J.R. and Vinten-Johansen J.: Nonanticoagulant heparin
inhibits NF-kappaB activation and attenuates myocardial
reperfusion injury. Am. J. Physiol. Heart Circ. Physiol.,
278 (6): H2084-93, 2000.
27- Cotran R.S. and Pober J.S.: Cytokine-endothelial interactions
in inflammation, immunity, and vascular injury. J.
Am. Soc. Nephrol., 1 (3): 225-35, 1990.
28- Zamboni W.A., Stephenson L.L., Roth A.C., Suchy H.
and Russell R.C.: Ischemia-reperfusion injury in skeletal
muscle: CD 18-dependent neutrophil-endothelial adhesion
and arteriolar vasoconstriction. Plast. Reconstr. Surg., 99
(7): 2002-7, 1997.
29- Petrasek P.F., Liauw S., Romaschin A.D. and Walker P.M.:
Salvage of postischemic skeletal muscle by monoclonal
antibody blockade of neutrophil adhesion molecule CD18.
J. Surg. Res., 56 (1): 5-12, 1994.
30- Sasaki G.H. and Pang C.Y.: Hemodynamics and viability
of acute neurovascular island skin flaps in rats. Plast.
Reconsfr. Surg., 65: 152-158, 1980.
31- Georgopoulos S., Mastorakos D., Kondi-Pafiti A., Katsenis
K., Arkadopoulos N., Kannas D., Archontaki M., Vestarchis
N. and Kokkalis G.: Hydroxyzine, cimetidine and
vitamin C in reducing skin flap necrosis in ischemiareperfusion
injury in rats. A comparative study. J. BUON,
17 (2): 377-82, 2012.
32- Faham S., Hileman R.E., Fromm J.R., Linhardt R.J. and
Rees D.C.: Heparin structure and interactions with basic
fibroblast growth factor. Science, 271: 1116-1120, 1996.
33- Jones H., Paul W. and Page C.P.: The effects of heparin
and related molecules on vascular permeability and neutrophil
accumulation in rabbit skin. Br. J. Pharmacol.,
135 (2): 469-79, 2002.
34- Hiebert L.M., Ping T. and Wice S.M.: Enhanced antithrombotic
effects of unfractionated heparin in rats after repeated
oral doses and its relationship to endothelial heparin
concentration. Br. J. Pharmacol., 153 (6): 1177-1184,
2008.
35- Hirigoyen M.B., Zhang W., Gordon R.E., Prabhat A.,
Urken M.L. and Weinberg H.: Additional benefit of heparin
in the thrombolytic salvage of ischemic skin flaps. Ann.
Plast. Surg., 35 (6): 612-9, 1995.
36- Springer T.A.: Adhesion receptors of the immune system.
Nature, 2; 346 (6283): 425-34, 1990.
37- Patarroyo M.: Leukocyte adhesion in host defense and
tissue injury. Clin. Immunol. Immunopathol., 60 (3): 333-
48, 1991.
38- Hubbard A.K. and Rothlein R.: Intercellular adhesion
molecule-1 (ICAM-1) expression and cell signaling cascades.
Free Radic. Biol. Med., 1; 28 (9): 1379-86, 2000.
39- Winn R.K., Ramamoorthy C., Vedder N.B., Sharar S.R.
and Harlan J.M.: Leukocyte-endothelial cell interactions
in ischemia-reperfusion injury. Ann. N. Y. Acad. Sci.,
832: 311-321, 1997.
100 Vol. 43, No. 1 / Study of Different Therapeutic Agents for the Prevention
40- Petrasek P.F., Liauw S., Romaschin A.D. and Walker P.M.:
Salvage of postischemic skeletal muscle by monoclonal
antibody blockade of neutrophil adhesion molecule CD18.
J. Surg. Res., 56 (1): 5-12, 1994.
41- Rabb H., O'Meara Y.M., Maderna P., Coleman P. and
Brady H.R.: Leukocytes, cell adhesion molecules and
ischemic acute renal failure. Kidney Int., 51 (5): 1463-
8, 1997.
42- DEMIRSEREN M.E., SARICI M., GOKREM S. and
YENIDUNYA S.: Protective effects of monoclonal antibody
to intercellular adhesion molecule-1 in venous
ischemia-reperfusion injury: Experimental study in rats.
J. Reconstr. Microsurg., 23 (1): 41-4, 2007.
43- Pan B.H., Tosa Y., Hosaka Y., Satoh K., Yokoyama T.,
SAIGA A. and Yenidunya M.O.: Effect of Monoclonal
Antibody to P-Selectin on Ischemia-Reperfusion Injury
in Skin Flap. Showa Univ. J. Med. Sci., 20 (1): 1-10,
2008.
44- Fukai T. and Ushio-Fukai M.: Superoxide dismutases:
Role in redox signaling, vascular function, and diseases.
Antioxid Redox Signal, 15; 15 (6): 1583-606, 2011.
45- Perry J.J., Shin D.S., Getzoff E.D. and Tainer J.A.: The
structural biochemistry of the superoxide dismutases.
Biochim. Biophys. Acta., 1804 (2): 245-62, 2010.
46- Klein M.B., Chan P.H. and Chang J.: Protective effects
of superoxide dismutase against ischemia-reperfusion
injury: development and application of a transgenic animal
model. Plast. Reconstr. Surg., 111 (1): 251-5, 2003